{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:21:07Z","timestamp":1780435267098,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12866-019-1390-1","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T08:02:56Z","timestamp":1547798576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Paromomycin production from Streptomyces rimosus NRRL 2455: statistical optimization and new synergistic antibiotic combinations against multidrug resistant pathogens"],"prefix":"10.1186","volume":"19","author":[{"given":"Asmaa A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir S.","family":"El-Housseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-850X","authenticated-orcid":false,"given":"Khaled M.","family":"Aboshanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Yassien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Hassouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"issue":"3","key":"1390_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijantimicag.2008,.09.001.","volume":"33","author":"E Durante-Mangoni","year":"2009","unstructured":"Durante-Mangoni E, Grammatikos A, Utili R, Falagas M. Do we still need the aminoglycosides? Int J Antimicrob Agents. 2009;33(3):201\u20135. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2008,.09.001.","journal-title":"Int J Antimicrob Agents"},{"key":"1390_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ja.2017.117","volume":"71","author":"Y Takahashi","year":"2017","unstructured":"Takahashi Y, Igarashi M. Destination of aminoglycoside antibiotics in the \u2018post-antibiotic era\u2019. J Antibiot (Tokyo). 2017;71:4\u201314. \n                    https:\/\/doi.org\/10.1038\/ja.2017.117\n                    \n                  .","journal-title":"J Antibiot (Tokyo)"},{"key":"1390_CR3","doi-asserted-by":"publisher","unstructured":"Piepersberg W, Aboshanab KM, Schmidt-Bei\u00dfner H, UF Wehmeier UF. The biochemistry and genetics of aminoglycoside producers, Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery: Wiley; 2007. p. 15\u2013118. \n                    https:\/\/doi.org\/10.1002\/9780470149676.ch2\n                    \n                  . \n                    https:\/\/archive.org\/details\/AminoglycosideAntibioticsFromChemicalBiologyToDrugDiscoveryDEVP.AryaWiley2007\n                    \n                  .","DOI":"10.1002\/9780470149676.ch2"},{"key":"1390_CR4","unstructured":"Frohardt R, Haskell TH, John E, Penner K. Antibiotic and methods for obtaining same: United states patent office; 1959. US2916485A. \n                    https:\/\/patents.google.com\/patent\/US2916485\n                    \n                  ."},{"issue":"10","key":"1390_CR5","doi-asserted-by":"publisher","first-page":"e0004118","DOI":"10.1371\/journal.pntd.0004118","volume":"9","author":"KM Jamil","year":"2015","unstructured":"Jamil KM, Haque R, Rahman R, Faiz MA, Bhuiyan AT, Kumar A, Hassan SM, Kelly H, Dhalaria P, Kochhar S, Desjeux P, Bhuiyan MA, Khan MM, Ghosh RS. Effectiveness study of Paromomycin IM injection (PMIM) for the treatment of visceral Leishmaniasis (VL) in Bangladesh. PLoS Negl Trop Dis. 2015;9(10):e0004118. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0004118\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"1390_CR6","first-page":"730","volume":"9","author":"GL Coffey","year":"1959","unstructured":"Coffey GL, Anderson LE, Fisher MW, Galbraith MM, Hillegas AB, Kohberger DL, Thomson PE, Weston KS, Ehrlich J. Biological studies of Paromomycin. Antibiotics Chemother. 1959;9(12):730\u20138.","journal-title":"Antibiotics Chemother"},{"key":"1390_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mycmed.2009.04.001","volume":"19","author":"D Thakur","year":"2009","unstructured":"Thakur D, Bora TC, Bordoloi GN, Mazumdar S. Influence of nutrition and culturing conditions for optimum growth and antimicrobial metabolite production by Streptomyces sp. 201. J Mycol Med. 2009;19:161\u20137. \n                    https:\/\/doi.org\/10.1016\/j.mycmed.2009.04.001\n                    \n                  .","journal-title":"J Mycol Med"},{"key":"1390_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3923\/tasr.2011.121.129","volume":"6","author":"HM Ibrahim","year":"2011","unstructured":"Ibrahim HM, Elkhidir EE. Response surface method as an efficient tool for medium optimization. Trends Appl Sci Res. 2011;6:121\u20139. \n                    https:\/\/doi.org\/10.3923\/tasr.2011.121.129\n                    \n                  .","journal-title":"Trends Appl Sci Res"},{"key":"1390_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1517\/14656566.2013.806486","volume":"12","author":"P Poulikakos","year":"2013","unstructured":"Poulikakos P, Falagas ME. Aminoglycoside therapy in infectious diseases. Expert Opin Pharmacother. 2013;12:1585\u201397. \n                    https:\/\/doi.org\/10.1517\/14656566.2013.806486\n                    \n                   PMID:23746121.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"1390_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1592\/phco.28.2.235","volume":"28","author":"AM Nicasio","year":"2008","unstructured":"Nicasio AM, Kuti JL, Nicolau DP. The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy. 2008;28(2):235\u201349. \n                    https:\/\/doi.org\/10.1592\/phco.28.2.235\n                    \n                  .","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1390_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1517\/14740338.2012.632631","volume":"11","author":"M Hagihara","year":"2012","unstructured":"Hagihara M, Crandon JL, Nicolau DP. The efficacy and safety of antibiotic combination therapy for infections caused by gram-positive and gram-negative organisms. Expert Opinion on Drug Safety. 2012;11(2):221\u201333. \n                    https:\/\/doi.org\/10.1517\/14740338.2012.632631\n                    \n                  .","journal-title":"Expert Opinion on Drug Safety"},{"issue":"4","key":"1390_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society & Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society & Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Ame J Respir Crit Care Med. 2005;171(4):388\u2013416. \n                    https:\/\/doi.org\/10.1164\/rccm.200405-644ST\n                    \n                  .","journal-title":"Ame J Respir Crit Care Med"},{"issue":"4","key":"1390_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/clinids\/7.Supplement_4.S559","volume":"7","author":"JD Allan","year":"1985","unstructured":"Allan JD, Moellering RC. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. Rev Infect Dis. 1985;7(4):559\u201371.","journal-title":"Rev Infect Dis"},{"key":"1390_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00268856","volume":"162","author":"DA Hopwood","year":"1978","unstructured":"Hopwood DA, Wright HM. Bacterial protoplast fusionrecombination in fused protoplasts of Streptomyces coelicolor. Mol Gen Genet. 1978;162:307\u201317.","journal-title":"Mol Gen Genet"},{"key":"1390_CR15","volume-title":"Practical Streptomyces genetics","author":"T Kieser","year":"2000","unstructured":"Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. Practical Streptomyces genetics. Norwich: The John Innes Foundation, John Innes centre; 2000."},{"key":"1390_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"A Bauer","year":"1996","unstructured":"Bauer A, Kirby W, Sherris JC, Truck M. Antibiotic susceptibility testing by a standardized signal disc method. Am J Clin Pathol. 1996;45:493\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"1390_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jac\/dkf083","volume":"49","author":"JM Andrews","year":"2002","unstructured":"Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2002;49(6):1049.","journal-title":"J Antimicrob Chemother"},{"key":"1390_CR18","unstructured":"CLSI document M100-S24. Performance Standards for Antimicrobials Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. Wayne: Performance Standards for Antimicrobial Susceptibility Testing: 24th Informational Supplement M100-S24. CLSI; 2014. \n                    https:\/\/clsi.org\/media\/1930\/m100ed28_sample.pdf\n                    \n                  ."},{"key":"1390_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u20132681. \n                    21793988\n                    \n                  . \n                    https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x\n                    \n                  .","journal-title":"Clin Microbiol Infect"},{"key":"1390_CR20","unstructured":"Miller JH. Experiments in molecular genetics. NY: Cold Spring Harbor Laboratory, Cold spring Harbor; 1972. p. 433. \n                    https:\/\/openlibrary.org\/books\/OL5298363M\/Experiments_in_molecular_genetics\n                    \n                  ."},{"issue":"4","key":"1390_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1128\/AAC.1.4.363","volume":"1","author":"L Anka","year":"1972","unstructured":"Anka L, Welty RE, Lucas GB. Antifungal spectra of Actinomycetes isolated from tobacco. Antimirob Agents chemother. 1972;1(4):363\u20135. \n                    https:\/\/doi.org\/10.1128\/AAC.1.4.363\n                    \n                  .","journal-title":"Antimirob Agents chemother"},{"key":"1390_CR22","first-page":"6","volume":"5","author":"HB Warren","year":"1955","unstructured":"Warren HB, Prokop JF, Grundy WE. Nonsynthetic media for antibiotic producing Actinomycetes. Antibiot Chemother. 1955;5:6\u201312 PMID: 24543340.","journal-title":"Antibiot Chemother"},{"key":"1390_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-08-025385-5.50013-4","volume-title":"Advance in Biotechnology","author":"TA El-Kersh","year":"1980","unstructured":"El-Kersh TA, Vezina C. Location of antimycin-A and melanin determination in auxotrophs of Streptomyces sp. M-506 and in thier prototrophic revertants. In: Moo-Young M, Vezina C, Kartersinch, editors. Advance in Biotechnology, vol. 3. Toranto: Pergamon Press; 1980. p. 37\u201342. \n                    https:\/\/doi.org\/10.1016\/B978-0-08-025385-5.50013-4\n                    \n                  ."},{"key":"1390_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1099\/00221287-17-1-96","volume":"17","author":"S Ball","year":"1957","unstructured":"Ball S, Bessell CJ, Mortimer A. The production of polyenic antibiotic by soil Streptomycetes. J Gen Microbial. 1957;17:96\u2013103. \n                    https:\/\/doi.org\/10.1099\/00221287-17-1-96\n                    \n                  .","journal-title":"J Gen Microbial"},{"key":"1390_CR25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1128\/AAC.27.5.798","volume":"27","author":"DH Nam","year":"1985","unstructured":"Nam DH, Ryu DY. Relationship between butirosin biosynthesis and sporulation in Bacillus circulans. Antimicrob Agents Chemo. 1985;27:798\u2013801. \n                    https:\/\/doi.org\/10.1128\/AAC.27.5.798\n                    \n                   PMID: \n                    2409916\n                    \n                  .","journal-title":"Antimicrob Agents Chemo"},{"key":"1390_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity. J Pharm Anal. 2016;6:71\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jpha.2015.11.005\n                    \n                  .","journal-title":"J Pharm Anal"},{"issue":"1","key":"1390_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/lam.12341","volume":"60","author":"S Clais","year":"2015","unstructured":"Clais S, Boulet G, Van Kerckhoven M, Lanckacker E, Delputte P, Maes L, Cos P. Comparison of viable plate count, turbidity measurement and real-time PCR for quantification of Porphyromonas gingivalis. Lett Appl Microbiol. 2015;60(1):79\u201384. \n                    https:\/\/doi.org\/10.1111\/lam.12341\n                    \n                  .","journal-title":"Lett Appl Microbiol"},{"key":"1390_CR28","unstructured":"State-Ease Handbook for experimenters: version 11.00. 2018 Minneapolis. \n                    https:\/\/www.statease.com\/pubs\/handbk_for_exp_sv.pdf\n                    \n                  ."},{"key":"1390_CR29","unstructured":"Clinical and Laboratory Standards Institute: Document M100-S23. CLSI; Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Wayne; 2013. \n                    https:\/\/www.statease.com\/docs\/v11\/tutorials\/index.html\n                    \n                  ."},{"key":"1390_CR30","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 10th ed. Wayne: CLSI document M07-A10. Clinical and Laboratory Standards Institute; 2015.","edition":"10"},{"issue":"1","key":"1390_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan G, Bayram A, Zer Y, Balci I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005;43(1):140\u20133. \n                    https:\/\/doi.org\/10.1128\/JCM.43.1.140-143.2005\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1390_CR32","doi-asserted-by":"publisher","first-page":"e0171349","DOI":"10.1371\/journal.pone.0171349","volume":"12","author":"MM Abdelkader","year":"2017","unstructured":"Abdelkader MM, Aboshanab KM, El-Ashry MA, Aboulwafa MM. Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations. PloS One. 2017;12(2):e0171349. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0171349\n                    \n                  .","journal-title":"PloS One"},{"key":"1390_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12088-007-0028-4","volume":"47","author":"S Khurana","year":"2007","unstructured":"Khurana S, Kapoor M, Gupta S, Kuhad RC. Optimization of alkaline xylanase production from Streptomyces violaceoruber under submerged fermentation using response surface methodology. Ind J Microbiol Stat. 2007;47:144\u201352. \n                    https:\/\/doi.org\/10.1007\/s12088-007-0028-4\n                    \n                  .","journal-title":"Ind J Microbiol Stat"},{"issue":"5","key":"1390_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11743-016-1845-4","volume":"19","author":"GS El-Housseiny","year":"2016","unstructured":"El-Housseiny GS, Aboulwafa MM, Aboshanab KA, Hassouna NA. Optimization of Rhamnolipid Productionby P. aeruginosa isolate P6. J Surfactants Deterg. 2016;19(5):943\u201355. \n                    https:\/\/doi.org\/10.1007\/s11743-016-1845-4\n                    \n                  .","journal-title":"J Surfactants Deterg"},{"key":"1390_CR35","doi-asserted-by":"publisher","unstructured":"Ghribi D, Abdelkefi-Mesrati L, Mnif I, Kammoun R, Ayadi I, Saadaoui I, Chaabouni-Ellouze S. Investigation of antimicrobial activity and statistical optimization of Bacillus subtilis SPB1 biosurfactant production in solid-state fermentation. J Biomed Biotechnol. 2012;373682. \n                    https:\/\/doi.org\/10.1155\/2012\/373682\n                    \n                  .","DOI":"10.1155\/2012\/373682"},{"key":"1390_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijbiomac.2013.11.041","volume":"64","author":"SM Abdel-Hafez","year":"2014","unstructured":"Abdel-Hafez SM, Hathout RM, Sammour OA. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs. Int J Biol Macromol. 2014;64:334\u201340. \n                    https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.11.041\n                    \n                  .","journal-title":"Int J Biol Macromol"},{"key":"1390_CR37","first-page":"2138","volume":"5","author":"A Kavitha","year":"2009","unstructured":"Kavitha A, Vijayalakshmi M. Cultural parameters affecting the production of bioactive metabolites by Nocardialevis MK-VL-113. J Appl Sci Res. 2009;5:2138\u201347.","journal-title":"J Appl Sci Res"},{"key":"1390_CR38","doi-asserted-by":"publisher","unstructured":"Singh LS, Sharma H, Talukdar NC. Production of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India. BMC Microbiol. 2014;14. \n                    https:\/\/doi.org\/10.1186\/s12866-014-0278-3\n                    \n                  .","DOI":"10.1186\/s12866-014-0278-3"},{"key":"1390_CR39","doi-asserted-by":"publisher","unstructured":"Ahsan T, Chen J, Wu Y, Irfan M. Application of response surface methodology for optimization of medium components for the production of secondary metabolites by Streptomyces diastatochromogenes KX852460. AMB Express. 2017;7. \n                    https:\/\/doi.org\/10.1186\/s13568-017-0388-z\n                    \n                  .","DOI":"10.1186\/s13568-017-0388-z"},{"issue":"1","key":"1390_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00001648-199801000-00004","volume":"9","author":"JM Lang","year":"1998","unstructured":"Lang JM, Rothman KJ, Cann CI. That confounded P-value. Epidemiology (Cambridge, Mass). 1998;9(1):7\u20138.","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"3","key":"1390_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2165\/00003495-199652030-00005","volume":"52","author":"MJ Rybak","year":"1996","unstructured":"Rybak MJ, McGrath BJ. Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician. Drugs. 1996;52(3):390\u2013405.","journal-title":"Drugs"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-019-1390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12866-019-1390-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-019-1390-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T19:13:25Z","timestamp":1579288405000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-019-1390-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1186\/s12866-019-1390-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AAI is assistant lecturer in the Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. GSE, is a lecturer in the Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. KMA, a professor and vice Dean for postgraduate affairs and Scientific Research, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. MAY, a professor and vice Dean for student affairs, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt and NAH is a professor of Microbiology and Immunology,. Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The study was approved by the hospital Ethics Committee and faculty of Pharmacy ethical committee Nr. Two hundred twenty-seven where both informed and written consents were obtained from the patients after explaining the purpose of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"18"}}